KAYAK2U

October 16, 2011

It’s a real whodunnit, that’s for sure.

It's tough being stoopit, I guess:

Two years into an escalating shortage of life-saving cancer drugs, regulators and lawmakers are still unable to identify why it is happening, let alone how to solve the problem.

Fucking Chuck Schumer has called for an investigation, as though he couldn't look in the mirror and see one of the culprits.

The video at the bottom is another fucking disgrace.  Bobble heads for government involvement.

Here's another story, with more buffoons:

Aiello’s doctor, Eyal Attar, uses much stronger language. “It’s absolutely outrageous that we cannot have these drugs available in our country – with one of the most advanced medical systems available to treat our patients. It is very frustrating and it makes me, quite frankly, angry.”

Fuck you, you moron.

And the usual… 

There is no single reason for the shortages. Some pharmaceutical companies have experienced manufacturing delays. Raw materials may be in short supply. And because most of these drugs have been off-patent for years, some drug companies don’t want to spend the money to upgrade lines to produce drugs with slim profit margins. 

But there is a single reason for the shortages.  It's called profit, the second to last word in the paragraph just above.  Life saving drugs, you know, drugs that people need to save their own lives, have slim profit margins, and apparently, people would rather die than pay more?  Is that it?

I don't think so.  It's just that someone or some thing is not allowed to pay more.  Maybe.  And who would be doing that forbidding?  Anyone?  Bueller?

But wait, there's more… 

There is money to be made, though. The shortage has given rise to a burgeoning “gray” market for hospital drugs.

“For some reason they have the supplies,” says Emory’s Emamifar, “but they’re selling at exorbitant prices.

FOR SOME REASON?  FOR SOME FUCKING REASON?

How does Emamifar manage to run a pharmacy at a major hospital and not know the reason?

And notice THAT.  It's not that people aren't allowed to pay more for their life saving drugs.  It's that the official suppliers are not allowed to CHARGE more.  When things are piped through the gray market, the increased price is paid, and gladly.

Oops, had another shortage story open (though now I think about it, I've got another half dozen drug shortage windows open… damn):

Similar to 2010, the drugs most affected by this year's shortages are older, sterile injectables, which are mostly used in hospitals. Part of the problem is that too few manufacturers produce the medications to meet the nation's needs, the FDA said.

Many companies choose not to make these products because they are not as profitable as other drugs, and manufacturing them is complex, medical experts say.

Yep, again.  People are dying for these drugs, but they are not sufficiently profitable to manufacture and deliver.  But the gray market means that patients and doctors are willing and able to pay more for these drugs, so that can only mean that the drug makers themselves are not allowed to charge a price that will please the market.

As I previously pointed out, quoting the inept and shoddy New York Times:

[C]ancer patients do not buy chemotherapy drugs from their local pharmacies the way they buy asthma inhalers or insulin. Instead, it is their oncologists who buy the drugs, administer them and then bill Medicare and insurance companies for the costs.

 Historically, this “buy and bill” system was quite lucrative; drug companies charged Medicare and insurance companies inflated, essentially made-up “average wholesale prices.”  The Medicare Prescription Drug, Improvement and Modernization Act of 2003, signed by President George W. Bush, put an end to this arrangement.  It required Medicare to pay the physicians who prescribed the drugs based on a drug’s actual average selling price, plus 6 percent for handling. And indirectly — because of the time it takes drug companies to compile actual sales data and the government to revise the average selling price — it restricted the price from increasing by more than 6 percent every six months.

The act had an unintended consequence. In the first two or three years after a cancer drug goes generic, its price can drop by as much as 90 percent as manufacturers compete for market share. But if a shortage develops, the drug’s price should be able to increase again to attract more manufacturers. Because the 2003 act effectively limits drug price increases, it prevents this from happening. The low profit margins mean that manufacturers face a hard choice: lose money producing a lifesaving drug or switch limited production capacity to a more lucrative drug.

Price controls on the manufacturers.

Someone call fucking Chuck Schumer.

MikeSoja - October 16, 2011 -- 10:37 pm    Filed in: Commies, Health care, Shortages  
« The eye of the law is upon them
Drug Desert Bloom »
As Happy As A Clam

Kayak2U.com

msoja RSS 2.0

Other's Pages









Search

Archive

November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  


  • Books4Sale



    Soja's GoodReads Books4Sale Cheap

  • Category Cloud


  • Tag Cloud